Soleno Therapeutics Inc (SLNO) earnings · rev $190.4M
These earnings events as JSON? API free 100/daySoleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
This SLNO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SLNO revenue for 2025-12-31 was $190.4M. Net income was $20.9M. SLNO currently screens at market cap $2.76B.
When the next SLNO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for SLNO. We will not invent a beat or miss.
Not investment advice. Full SLNO research stays on the stock page; the tape stays on the quote page.
SLNO earnings FAQ
What are SLNO's latest revenue and net income?
Latest cached Soleno Therapeutics Inc (SLNO) revenue for Dec 31, 2025 was $190.4M. Net income was $20.9M. Statements: https://lician.com/financials/slno
What is SLNO's latest diluted EPS?
Latest cached Soleno Therapeutics Inc (SLNO) diluted EPS for Dec 31, 2025 was $0.39.
What period does the latest SLNO earnings print cover?
The latest cached Soleno Therapeutics Inc (SLNO) earnings print covers Dec 31, 2025.
Where are SLNO earnings listed?
Cached earnings facts for Soleno Therapeutics Inc (SLNO) are listed at https://lician.com/earnings/slno. Statements: https://lician.com/financials/slno
Not investment advice.